Events

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presented at the 2023 ARCS Annual Conference

Presentations given by the TGA at the 2023 ARCS Annual Conference, 6-8 June 2023.

Presented at the 2023 ARCS Annual Conference

UDI Webinar 16 – Australian UDI update and guest speakers on the value of UDI for procurement and inventory management in hospitals.

The TGA Good Manufacturing Practice Forum returned to Sydney on 21 March 2023.

This webinar will address the recent announcement by the TGA that medicines containing psilocybin and MDMA will be conditionally classified as Schedule 8 (controlled drug) in the Poisons Standard.

This webinar will address the recent announcement by the TGA that medicines containing psilocybin and MDMA will be classified as Schedule 8 (controlled drug) when prescribed by a psychiatrist.

In this webinar we will provide an update on the Australian UDI implementation and discuss the challenges and benefits of having UDI in healthcare and the role of hospitals and other healthcare providers in relation to using UDI.

This webinar will explain labelling requirements for finished MCP in detail.

This webinar will guide you through the process of charging for regulatory activities, the medicinal cannabis funding model and the fees and charges structure and amounts proposed to commence on 1 July 2023.

The final webinar in this series will explore the impact changes to the EU MDR will have on consent to supply and market notifications.

The final webinar in this series will explore the impact changes to the EU MDR will have on consent to supply and market notifications.

This webinar will focus on how the changes under the EU MDR will affect manufacturer evidence and variations to the ARTG.

Changes to the formatting and structure of the Poisons Standard will come into effect from 1 February 2023

This is the second in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR, with a focus on manufacturer evidence and variations to the ARTG.

Presentation on the new formatting and structure of the Poisons Standard

This webinar will outline what regulatory actions are required as a result of changes under the EU MDR, and how the TGA will streamline the transition.

This is the first in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR.